Abstract
The value of the fibrotic focus (FF) as a marker of intra-tumoral hypoxia in invasive breast carcinoma was assessed by studying its relationship with the expression of the hypoxia-induced carbonic anhydrase IX (CA IX), angiogenesis indices and prognosis.
CA IX expression was immunohistochemically detected in 2 independent study groups, totaling 184 patients, and correlated with tumor characteristics, angiogenesis related parameters and patient outcome by univariate analysis.
CA IX immunostaining scores in carcinoma cells and in tumoral fibroblasts were significantly higher in expansively growing tumors (p = 0.0001 and p < 10−4, respectively), containing an FF (p = 0.0004 and p < 10−4) and showing high histological grade (p = 0.016 and p = 0.0006).
Microvessel density, quantified by Chalkley counting, was correlated with CA IX expression both in the carcinoma cells and in the fibroblasts (p = 0.0076 and p = 0.0025) and with the presence and relative size of an FF (p = 0.006). The fraction of proliferating endothelial cells was positively correlated with CA IX scores in the fibroblasts (r = 0.4, p = 0.02) and with the presence of an FF (p = 0.02). CA IX scores in the fibroblasts – and to a lesser extent in the carcinoma cells – were associated with a higher relapse rate (p = 0.006) and a worse overall survival (p = 0.003). The highest CA IX immunostaining scores were found in the fibroblasts of large FF occupying more than one-third of the tumor. A large FF was associated with worse overall survival in a consecutive patient group (p = 0.01) and with shorter disease-free (p = 0.02) and overall survival (p = 0.0005) in T1-2N0 breast cancer patients.
The strong association of CA IX expression with the presence of an FF shows that the latter is a marker of intra-tumoral hypoxia. FF is useful as a surrogate marker of hypoxia-driven ongoing angiogenesis and is associated with a higher relapse rate and a worse overall survival.
Similar content being viewed by others
References
Pastorekova S, Zavadova Z, Kostal M, Babusikova O, Zavada J: A novel quasi-viral agent, MaTu, is a twocomponent system. Virology 187: 620–626, 1992
Pastorek J, Pastorekova S, Callebaut I, Mornon JP, Zelnik V, Opavsky R, Zat'ovicova M, Liao S, Portetelle D, Stanbridg EJ et al.: Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 9: 2877–2888, 1994
Ivanov S, Liao SY, Ivanova A, Danilkovitch-Miagkova A, Tarasova N, Weirich G, Merrill MJ, Proescholdt MA, Oldfield EH, Lee J, Zavada J, Waheed A, Sly W, Lerman MI, Stanbridge EJ: Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol 158: 905–919, 2001
Wykoff CC, Beasly NJ, Watson PH, Campo L, Chia SK, English R, Pastorek J, Sly WS, Ratcliffe P, Harris AL: Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am J Pathol 158: 1011–1019, 2001
Wykoff CC, Beastly NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL: Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60: 7075–7083, 2000
Van Berkel M, van der Groep P, Shvarts A, Bos R, Greijer A, Harris AL, van der Wall E, van Diest P: Breast Cancer Res Treat 76(Suppl 1): S146, 2002
Loncaster JA, Harris AL, Davidson SE, Logue JP, Hunter RD, Wykoff CC, Pastorek J, Ratcliffe PJ, Stratford IJ, West CM: Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 61: 6394–6399, 2001
Olive PL, Aquino-Parsons C, MacPhail SH, Liao SY, Raleigh JA, Lerman MI, Stanbridge EJ: Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res 61: 8924–8929, 2001
Beasley NJ, Wykoff CC, Watson PH, Leek R, Turley H, Gatter K, Pastorek J, Cox GJ, Ratcliffe P, Harris AL: Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis and microvessel density. Cancer Res 61: 5262–5267, 2001
Höckel M, Vaupel P: Tumor hypoxia: definitions and current clinical, biologic and molecular aspects. J Natl Cancer Inst 2001 93: 266–276, 2001
Vaupel P, Höckel M: Predictive power of the tumor oxygenation status. Adv Exp Med Biol 471: 533–539, 1999
Harris AL: Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38–47, 2002
Knowles HJ, Harris AL: Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis. Breast Cancer Res 3: 318–322, 2001
Chia SK, Wykoff CC, Watson PH, Han C, Leek RD, Pastorek J, Gatter KC, Ratcliffe P, Harris AL: Prognostic significance of Fibrotic focus and CA IX in breast cancer 147 a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 19: 3660–3668, 2001
Colpaert C, Vermeulen P, Jeuris W, van Beest P, Goovaerts G, Weyler J, Van Dam P, Dirix L, Van Marck E: Early distant relapse in ‘node negative’ breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour. J Pathol 193: 442–449, 2001
Colpaert C, Vermeulen P, van Beest P, Goovaerts G, Weyler J, Van Dam P, Dirix L, Van Marck E: Intra-tumoral hypoxia resulting in the presence of a fibrotic focus is an independent predictor of early distant relapse in lymph-node negative breast cancer patients. Histopathology 39: 416–425, 2001
Elston CW: Grading of invasive carcinoma of the breast. In: Page DL, Anderson TJ (eds) Diagnostic Histopathology of the Breast. Churchill Livingstone, New York, 1987, pp 302–311
Bloom H, Richardson W: Histological grading and prognosis in breast cancer: a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359–77, 1957
Hasebe T, Tsuda H, Hirohashi S, Shimosato Y, Tsubono Y, Yamamoto H, Mukai K: Fibrotic focus in infiltrating ductal carcinoma of the breast: a significant histopathological prognostic parameter for predicting the long-term survival of the patients. Breast Cancer Res Treat 49: 195–208, 1998
Chalkley HW: Method for the quantitative morphologic analysis of tissues. J Natl Cancer Inst 4: 47–53, 1943
Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harris AL: Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count and computer image analysis. J Pathol 177: 275–283, 1995
Hansen S, Grabau DA, Rose C, Bak M, Sorensen FB: Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. Lab Invest 78: 1563–1573, 1998
Hansen S, Grabau DA, Sorensen FB, Bak M, Vach W, Rose C: The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients. Clin Cancer Res 6: 139–146, 2000
Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, McCullogh P, Pezzella F, Viale G, Weidner N, Harris AL, Dirix LY: Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 32A: 2474–2484, 1996
Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M, Beliën JAM, de Waal RMW, Van Marck E, Magnani E, Weidner N, Harris AL, Dirix LY: Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid tumours. Eur J Cancer 38: 1564–1579, 2002
Valkovic T, Dobrila F, Melato M, Sasso F, Rizzardi C, Jonjic N: Correlation between vascular endothelial cell growth factor, angiogenesis, and tumour-associated macrophages in invasive ductal breast carcinoma. Virchows Arch 440: 583–588, 2002
Jonjic N, Valkovic T, Lucin K, Iternicka Z, Krstulja M, Mustac E, Dobi-Babic R, Sasso F, Melato M: Comparison of the microvessel density with tumor associated macrophages in invasive breast carcinoma. Anti Cancer Res 18: 3767–3770, 1998
Hasebe T, Tsuda H, Hirohashi S, Shimosato Y, Iwai M, Imoto S, Mukai K: Fibrotic focus in invasive ductal carcinoma: an indicator of high tumor aggressiveness. Jpn J Cancer Res 87: 385–394, 1996
Hasebe T, Tsuda H, Tsubono Y, Imoto S, Mukai K: Fibrotic focus in invasive ductal carcinoma of the breast: a histopathological prognostic parameter for tumor recurrence and tumor death within 3 years after the initial operation. Jpn J Cancer Res 89: 590–599, 1997
Hasebe T, Sasaki S, Imoto S, Mukai K, Yokose T, Ochiai A: Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study. Mod Pathol 15: 502–516, 2002
Jitsuiki Y, Hasebe T, Tsuda H, Imoto S, Tsubono Y, Sasaki S, Mukai K: Optimizing microvessel counts according to tumor zone in invasive ductal carcinoma of the breast. Mod Pathol 12: 492–498, 1999
Hasebe T, Sasaki S, Imoto S, Ochiai A: Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast. Mod Pathol 14: 325–337, 2001
Hasebe T, Sasaki S, Imoto S, Ochiai A: Proliferative activity of intratumoral fibroblasts is closely correlated with lymph node and distant organ metastases of invasive ductal carcinoma of the breast. Am J Pathol 156: 1701–1710, 2000
Jiang BH, Semenza GL, Bauer C, Marti HH: Hypoxiainducible factor-1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol 271: C1172–C1180, 1996
Raghunand N, He X, van Sluis R, Mahoney B, Baggett B, Taylor CW, Paine-Murrietta G, Roe D, Bhujwalla ZM, Gillies RJ: Enhancement of chemotherapy by manipulation of tumour pH. Br J Cancer 80: 1005–1011, 1999
Noël A, Hajitou A, L'Hoir C, Maquoi E, Baramova E, Lewalle JM, Remacle A, Kebers F, Brown P, Calberg-Bacq CM, Foidart JM: Inhibition of stromal matrix metalloproteïnases: effects of breast-tumor promotion by fibroblasts. Int J Cancer 76: 267–273, 1998
Hlatky L, Tsionou C, Hahnfeldt P, Normal Coleman C: Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. Cancer Res 54: 6083–6086, 1994
Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K, Koike M, Inadera H, Matsushima K: Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis and survival in human breast cancer. Clin Cancer Res 6: 3282–3289, 2000
Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C: Macrophages and angiogenesis. J Leukocyte Biol 55: 410–422, 1994
Leek RD, Landers RJ, Harris AL, Lewis CE: Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 79: 991–995, 1999
Lewis JS, Landers RJ, Underwood JCE, Harris AL, Lewis CE: Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinoma. J Pathol 192: 150–158, 2000
Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL: Association of macrophage infiltration with angiogenesis and prognosis in invasive breast-carcinoma. Cancer Res 56: 4625–4629, 1996
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Colpaert, C.G., Vermeulen, P.B., Fox, S.B. et al. The Presence of a Fibrotic Focus in Invasive Breast Carcinoma Correlates with the Expression of Carbonic Anhydrase IX and is a Marker of Hypoxia and Poor Prognosis. Breast Cancer Res Treat 81, 137–147 (2003). https://doi.org/10.1023/A:1025702330207
Issue Date:
DOI: https://doi.org/10.1023/A:1025702330207